Erschienen in:
01.08.2011 | Editorial
Green tea: a new option for the prevention or control of osteoarthritis
verfasst von:
Santosh K Katiyar, Chander Raman
Erschienen in:
Arthritis Research & Therapy
|
Ausgabe 4/2011
Einloggen, um Zugang zu erhalten
Abstract
IL-1β is a major cytokine driving the inflammatory processes leading to the pathophysiology of osteoarthritis and other inflammatory diseases. Blockade of IL-1β activity using substances such as the naturally occurring IL-1 receptor antagonist or anti-IL-1β monoclonal antibody are currently being used or tested as therapy. However, such treatments are ineffective in osteoarthritis. In a recent study, epigallocatechin-3-gallate, a green tea polyphenol, was found to be effective in reducing IL-1β-induced inflammatory cytokines, TNFα, IL-6, granulocyte-macrophage colony-stimulating factor and several chemokines from human chondrocytes. The use of green tea polyphenols may be beneficial as a therapeutic addition to biologics that control IL-1β activity by increasing effectiveness and/or reducing dosage.